Insider Transactions in Q2 2025 at Rivian Automotive, Inc. (RIVN)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2025
|
Karen Boone Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,812
+14.6%
|
-
|
|
Jun 18
2025
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,812
+9.46%
|
-
|
|
Jun 18
2025
|
Aidan N. Gomez Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,020
-2.59%
|
$13,260
$13.39 P/Share
|
|
Jun 18
2025
|
Aidan N. Gomez Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,812
+29.89%
|
-
|
|
Jun 18
2025
|
John Krafcik Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,812
+22.03%
|
-
|
|
Jun 18
2025
|
Peter Krawiec Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,812
+17.11%
|
-
|
|
Jun 18
2025
|
Rose M Marcario Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,812
+11.81%
|
-
|
|
Jun 18
2025
|
Sanford Harold Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,812
+8.15%
|
-
|
|
May 20
2025
|
Aidan N. Gomez Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,625
+50.0%
|
-
|
|
May 19
2025
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,428
-4.59%
|
$1,071,420
$15.36 P/Share
|
|
May 19
2025
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,428
+4.39%
|
$142,856
$2.63 P/Share
|
|
May 16
2025
|
Claire Mc Donough Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,185
-2.04%
|
$257,775
$15.39 P/Share
|
|
May 15
2025
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
107,144
-6.74%
|
$1,607,160
$15.25 P/Share
|
|
May 15
2025
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
107,144
+6.31%
|
$214,288
$2.63 P/Share
|
|
May 15
2025
|
Robert J Scaringe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,211
-1.54%
|
$324,954
$14.82 P/Share
|
|
May 15
2025
|
Claire Mc Donough Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,577
-1.12%
|
$134,078
$14.82 P/Share
|
|
May 13
2025
|
Claire Mc Donough Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,937
-1.15%
|
$149,055
$15.0 P/Share
|
|
Apr 21
2025
|
Robert J Scaringe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
653,311
+30.25%
|
-
|
|
Apr 21
2025
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,713
-4.02%
|
$392,843
$11.46 P/Share
|
|
Apr 21
2025
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,713
+3.86%
|
$71,426
$2.63 P/Share
|
|
Apr 21
2025
|
Claire Mc Donough Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
522,649
+37.76%
|
-
|
|
Apr 21
2025
|
Sreela Venkataratnam CAO |
BUY
Grant, award, or other acquisition
|
Direct |
522,649
+50.0%
|
-
|
|
Apr 21
2025
|
Sanford Harold Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,687
+0.97%
|
-
|
|
Apr 21
2025
|
Peter Krawiec Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,088
+1.65%
|
-
|
|
Apr 07
2025
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,429
-7.73%
|
$785,719
$11.25 P/Share
|
|
Apr 07
2025
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,429
+7.17%
|
$142,858
$2.63 P/Share
|